Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
Kawashima Y, Ishimoto O, Miyauchi E, Sakakibara T, Harada T, Usui K, Inoue A, Sugawara S. Kawashima Y, et al. Among authors: miyauchi e. Thorac Cancer. 2023 Sep;14(27):2804-2810. doi: 10.1111/1759-7714.15076. Epub 2023 Aug 17. Thorac Cancer. 2023. PMID: 37589158 Free PMC article. Clinical Trial.
Pulmonary adenocarcinoma in situ: analyses of a large series with reference to smoking, driver mutations, and receptor tyrosine kinase pathway activation.
Sato S, Motoi N, Hiramatsu M, Miyauchi E, Ono H, Saito Y, Nagano H, Ninomiya H, Inamura K, Uehara H, Mun M, Sakao Y, Okumura S, Tsuchida M, Ishikawa Y. Sato S, et al. Among authors: miyauchi e. Am J Surg Pathol. 2015 Jul;39(7):912-21. doi: 10.1097/PAS.0000000000000458. Am J Surg Pathol. 2015. PMID: 25970685
TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
Matsuda T, Miyauchi E, Hsu YW, Nagayama S, Kiyotani K, Zewde M, Park JH, Kato T, Harada M, Matsui S, Ueno M, Fukuda K, Suzuki N, Hazama S, Nagano H, Takeuchi H, Vigneswaran WT, Kitagawa Y, Nakamura Y. Matsuda T, et al. Among authors: miyauchi e. Oncoimmunology. 2019 Mar 22;8(6):e1588085. doi: 10.1080/2162402X.2019.1588085. eCollection 2019. Oncoimmunology. 2019. PMID: 31069156 Free PMC article.
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
Miyauchi E, Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T; North-East Japan Study Group. Miyauchi E, et al. Jpn J Clin Oncol. 2015 Jul;45(7):670-6. doi: 10.1093/jjco/hyv054. Epub 2015 Apr 15. Jpn J Clin Oncol. 2015. PMID: 25877748 Clinical Trial.
Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
Yamane Y, Shiono A, Ishii Y, Isobe K, Miyauchi E, Kishi K, Nishino M, Sugawara S, Ko R, Koyama N, Yabuki Y, Kobayashi K. Yamane Y, et al. Among authors: miyauchi e. Jpn J Clin Oncol. 2016 Dec;46(12):1135-1142. doi: 10.1093/jjco/hyw124. Epub 2016 Sep 21. Jpn J Clin Oncol. 2016. PMID: 27655904
128 results